سعر ترافوسويكس بلس Travoswix Plus‏ قطرة للعين 2.5مل 2026

Fixed-combination travoprost + timolol eye drops, 2.5 mL bottle.

• Most frequent treatment-related adverse reaction in clinical studies (2,170 patients) was ocular hyperaemia (12.0%).International label, equivalent formulation · electronic medicines compendium (emc), UK

• Hypersensitivity to the active substances, excipients or other beta blockers; reactive airway disease including bronchial asthma or history of asthma, severe COPD; sinus bradycardia, sick sinus syndrome, sino-atrial block, uncontrolled second- or third-degree AV block; overt cardiac failure, cardiogenic shock; severe allergic rhinitis and corneal dystrophies.International label, equivalent formulation · electronic medicines compendium (emc), UK

• Timolol is absorbed systemically: beta-blocker cardiovascular and pulmonary reactions can occur (caution in cardiovascular disease, first-degree heart block, severe peripheral circulatory disorders, mild/moderate COPD); bronchospasm deaths reported with ophthalmic beta blockers in asthma; may mask hypoglycaemia; may potentiate myasthenic weakness; caution in corneal disease.International label, equivalent formulation · electronic medicines compendium (emc), UK
• Travoprost component may increase iris pigmentation and change eyelashes and periorbital tissue.International label, equivalent formulation · electronic medicines compendium (emc), UK

• Oral calcium channel blockers, beta blockers, antiarrhythmics (incl. amiodarone), digitalis glycosides, parasympathomimetics, guanethidinePotential additive effects resulting in hypotension and/or marked bradycardia.electronic medicines compendium (emc), UK
• CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine)Potentiated systemic beta blockade (e.g. decreased heart rate, depression) reported with timolol.electronic medicines compendium (emc), UK
• ClonidineHypertensive reaction to sudden clonidine withdrawal can be potentiated by beta blockers.electronic medicines compendium (emc), UK

• Travoprost has harmful pharmacological effects on pregnancy and/or the fetus/newborn; do not use during pregnancy unless clearly necessary. Must not be used in women of childbearing potential unless adequate contraception is in place.International label, equivalent formulation · electronic medicines compendium (emc), UK
• Timolol is excreted in breast milk; travoprost excretion in human milk unknown (excreted in animal milk). Use by breast-feeding women is not recommended.International label, equivalent formulation · electronic medicines compendium (emc), UK